We motivate patients to take control of their own oral anticoagulation therapy
More than 4.000.000 patients in Europe are living on long-term oral anticoagulation. ISMAAP activities are focussed around these anticoagulated patients to offer them a better quality of life.
This web site contains comprehensive information about this subject, as well as information about living with lifelong anticoagulation.
In the name of the authors, we would like to thank you for taking interest in these subjects. Managing Board of the ISMAAP, Geneva.
"Active, informed patients are natural partner in managing anticoagulation therapy efficiently"
Living with anticoagulants
We invite you to a journey between Scylla and Charybdis (please click on the picture below).
PETITION „Pour le remboursement de l’automesure chez les patients sous AVK
Date de cloture 23/06/09!
Nous avons également crée une pétition que nous adresserons au Ministre de la Santé, Madame Roselyne Bachelot- Narquin:
Signer la pétition :
www.mesopinions.com/Pour-le-remboursement-de-l-automesure-chez-les-patients-sous-AVK-petition-petitions-210e0b49d900f10c60c130638ee31bbd.html
Par soucis de confidentialité, seuls votre prénom et votre commentaire (non obligatoire) seront visibles sur le site "mes Opinions.com".
Toutes les autres informations données (Nom, nationalité…) sont masquées et vos coordonnées ne seront pas revendues à des tiers.
Après avoir signé la pétition, vous recevrez un mail « de validation » confirmant que vos coordonnées ont bien été enregistrées. Pour confirmer définitivement votre inscription, vous devez cliquer sur le lien proposé dans ce mail.
IMPORTANT : Vérifiez que votre signature a bien été enregistrée en cliquant, en haut de la pétition sur "Voir la liste des signataires"
Petição Pública
Caros Amigos,
Acabei de ler e assinar esta petição online:
„Comparticipação dos aparelhos portáteis e respectivos acessórios para a medição dos valores de INR.“
www.peticaopublica.com/?pi=APDA
Eu pessoalmente concordo com esta petição e acho que também podes concordar.
Subscreve a petição aqui
www.peticaopbulica.com/?pi=APDA
e divulga-a pelos teus contactos.
Obrigado
Maria da Glória Ferro dos Santod
Menorrhagia is common in patients on oral anticoagulation with vitamin-k-antagonist phenprocoumon
Objectives: To assess the menstrual blood flow of 46 women on long term oral anticoagulation (OAC) with phenprocoumon in comparison to normal values from the literature.
What about quality in anticoagulation?
During the 53. annual meeting of the German society for thrombosis and hemostasis research (GTH) in Vienna, Austria (Feb. 4th- 7th, 2009), the occurrence of thrombotic events and the respective therapies were discussed in depth.
Reimbursement in Europe
In some countries, doctors generally or the thrombosis service agree that patients should manage the self-monitoring of long-term oral anticoagulation on their own and take control of their anticoagulation therapy. In these countries, reimbursement of the necessary equipment for self-monitoring is usually granted by the national health insurance authority.
However, in other countries, self-monitoring of long-term oral anticoagulation can be carried out only in very close cooperation with the general practitioner and/or the lab. In these countries, reimbursement by the national health insurance authority of the necessary equipment is for self-monitoring not yet possible.
Education, Training, and Self-Management not only for Seniors
Patient education and training is a substantial part being anticoagulated in order to know how to deal properly with Oral Anticoagulants.
Misconceptions that alarm anticoagulated patients
We check everyday that many anticoagulated patients are overwhelmed and scared by warnings and prohibitions, usually absurd and unfounded, from relatives or friends, and even sometimes from the medical staff. We refer to drugs and food that anticoagulated patients are or not able to have.
Assemblée Générale GIRTAC-VIBAST du samedi 31 janvier 2009
C’est dans le cadre historique et prestigieux de l’Hôpital-Musée Notre-Dame à la Rose à Lessines que s’est tenue l’Assemblée Générale Annuelle de l’Asssociation Belge GIRTAC-VIBAST.
World Heart Day 2008, Sunday 28th September
HELP YOUR PATIENTS TO KNOW THEIR RISK!
(Geneva) By the year 2025 it is estimated that more than 1.5 billion people , or nearly one in three adults over the age of 25, will have high blood pressure, one of the biggest single risk factors for cardiovascular disease (CVD), the world’s number one killer. High blood pressure and CVD are increasing in prevalence, including among the young, and need immediate action and attention.
ISTH-Vienna July 2-5, 2008
The 54th Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis took place in the Hotel Hilton, Vienna, July 2–5, 2008.
• Management of anticoagulation in patients with atrial fibrillation
1. Rationale and methods of implement anticoagulant treatment in patients with
atrial fibrillation
Gregory Lip, Birmingham, UK
2. Interruption of anticoagulant treatment around invasive procedures
Sam Schulman, Hamilton, Canada
3. Role of self-management of anticoagulation in patients with atrial fibrillation
Marcel Levi, Amsterdam, The Netherlands
4. Introduction
Christian Schaefer, Geneva, Switzerland
Embolism and Thrombosis
As a member of the Health Group FEASAN, I considered it to be advisable to write this short article on thrombosis and embolism in order to clarify some concepts that might help us to understand appropriately their right meaning. This description is due to the fact that, on many occasions, both terms are mentioned indistinctly, missing their exact differences, either etiological, structural or clinic ones.
Remboursement pour les enfants
Prise en charge du CoaguChek®XS ou de l’INRatio® pour les enfants.
Les enfants, de moins de 18 ans, sous AVK au long court pourront à partir du 7 Juillet 2008, bénéficier d’une prise en charge totale des autotests de l’INR (CoaguChek® XS, INRatio®) et de leurs bandelettes (en boite de 12 pour l’ INRatio® et en boite de 24 pour le CoaguChek® XS).
Les arrêtés ont été publiés ce matin au Journal Officiel de la République Française ( N° 0146 du 24 Juin 2008).
Safety for anticoagulated patients in Spain
Control of anticoagulation is carried out daily to near one hundred thousand patients at Spanish Hospitals and Health Centres. The Spanish Anticoagulated Patients Associations need to question whether such controls are carried out correctly at those Hospitals and Health Centres.
ISMAAP Conference on Anticoagulant Therapy
The 3rd International Patient/Physician Conference on Oral Anticoagulant Therapy took place from Oct 18 until Oct. 21, 2007 in Salzburg. Representatives of nine national patient organisations (Austria, Belgium, Denmark, Germany, France, Italy, the Netherlands, Spain and Switzerland) and physicians from Austria, Germany and Switzerland discussed how patients could be helped to have a better understanding of their therapy and manage their own INR monitoring.
Congress of the European Society of Cardiology (ESC) 2007 in Vienna
The international ISMAA/ISMAAP-Symposium “Management of anticoagulation in atrial fibrillation” (Sunday, Sept 2nd 2007) was of interest for 300 cardiologists around the world.
The 90 minutes session was moderated by Prof. Dr. Marcel Levi, Amsterdam/The Netherlands.
ISTH - Geneva July, 2007
The ISMAAP/ISMAA-Symposium "Living with Anticoagulants", July 9, 2007, on the occasion of the XXIst Congress of the International Society on Thrombosis and Haemostasis was very well attended with over 400 delegates.
You will find the summaries of the speakers: Marcel Levi, MD PhD; Prof. Dr. F.R. Rosendaal; Hannelore Rott, MD and Eve Knight
Anticoagulation Forum's 9th National Conference
May 3-5, 2007
Chicago, Illinois, USA
Prof. Jack Ansell, president and founder of the AnticoagulationForum, Boston, was very pleased on how this conference has grown and become an important source of information and education for its attendees.
World Congress of Cardiology
The ISMAAP-Symposium "Living with Anticoagulants" of the World Congress of Cardiology in Barcelona, Spain (Sept. 3rd, 2006) was dedicated to the exchange of experience between patients, who need life time anticoagulants treatment and this cardiologists.
Watch (video) the closing remarks of Prof. Jack Ansell...
Last modification: April, 29th, 2009